| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |